Current understanding of coronary artery calcification

Wei Liu, Yue Zhang, Cheuk-Man Yu, Qing-Wei Ji, Meng Cai, Ying-Xin Zhao, Yu-Jie Zhou, Wei Liu, Yue Zhang, Cheuk-Man Yu, Qing-Wei Ji, Meng Cai, Ying-Xin Zhao, Yu-Jie Zhou

Abstract

Coronary artery calcification (CAC) is highly prevalent in patients with coronary heart disease (CHD) and is associated with major adverse cardiovascular events. There are two recognized type of CAC-intimal and medial calcification, and each of them have specific risk factors. Several theories about the mechanism of vascular calcification have been put forward, and we currently believe that vascular calcification is an active, regulated process. CAC can usually be found in patients with severe CHD, and this asymptomatic phenomenon make early diagnosis of CAC important. Coronary computed tomographic angiography is the main noninvasive tool to detect calcified lesions. Measurement of coronary artery calcification by scoring is a reasonable metric for cardiovascular risk assessment in asymptomatic adults at intermediate risk. To date, effective medical treatment of CAC has not been identified. Several strategies of percutaneous coronary intervention have been applied to CHD patients with CAC, but with unsatisfactory results. Prognosis of CAC is still a major problem of CHD patients. Thus, more details about the mechanisms of CAC need to be elucidated in order to improve the understanding and treatment of CAC.

Keywords: Coronary artery calcification; Diagnostic method; Pathogenesis; Risk factors.

References

    1. Kalra SS, Shanahan CM. Vascular calcification and hypertension: cause and effect. Ann Med. 2012;44(Suppl 1):S85–S92.
    1. Greenland P, LaBree L, Azen SP, et al. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA. 2004;291:210–215.
    1. Demer LL, Tintut Y. Vascular calcification: pathobiology of a multifaceted disease. Circulation. 2008;117:2938–2948.
    1. Wong ND, Kouwabunpat D, Vo AN, et al. Coronary calcium and atherosclerosis by ultrafast computed tomography in asymptomatic men and women: relation to age and risk factors. Am Heart J. 1994;127:422–430.
    1. Goel M, Wong ND, Eisenberg H, et al. Risk factor correlates of coronary calcium as evaluated by ultrafast computed tomography. Am J Cardiol. 1992;70:977–980.
    1. Kronmal RA, McClelland RL, Detrano R, et al. Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the multi-ethnic study of atherosclerosis (MESA) Circulation. 2007;115:2722–2730.
    1. Spence LA, Weaver CM. Calcium intake, vascular calcification, and vascular disease. Nutr Rev. 2013;71:15–22.
    1. Raffield LM, Agarwal S, Cox AJ, et al. Cross-sectional analysis of calcium intake for associations with vascular calcification and mortality in individuals with type 2 diabetes from the diabetes heart study. Am J Clin Nutr. 2014;100:1029–1035.
    1. Demer LL, Tintut Y. Vascular calcification: pathobiology of a multifaceted disease. Circulation. 2008;117:2938–2948.
    1. Johnson RC, Leopold JA, Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res. 2006;99:1044–1059.
    1. Abedin M, Tintut Y, Demer LL. Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol. 2004;24:1161–1170.
    1. Goodman WG, London G, Amann K, et al. Vascular calcification in chronic kidney disease. Am J Kidney Dis. 2004;43:572–579.
    1. Wang L, Jerosch-Herold M, Jacobs DR, Jr, et al. Coronary artery calcification and myocardial perfusion in asymptomatic adults. J Am Coll Cardiol. 2006;48:1018–1026.
    1. Spence LA, Weaver CM. Calcium intake, vascular calcification, and vascular disease. Nutr Rev. 2013;71:15–22.
    1. Ix JH, Katz R, de Boer IH, et al. Fetuin-A is inversely associated with coronary artery calcification in community-living persons: the multi-ethnic study of atherosclerosis. Clin Chem. 2012;58:887–895.
    1. Leopold J. MicroRNAs regulate vascular medial calcification. Cells. 2014;3:963–980.
    1. Goettsch C, Rauner M, Pacyna N, et al. MiR-125b regulates calcification of vascular smooth muscle cells. Am J Pathol. 2011;179:1594–1600.
    1. Liao XB, Zhang ZY, Yuan K, et al. MiR-133a modulates osteogenic differentiation of vascular smooth muscle cells. Endocrinology. 2013;154:3344–3352.
    1. Cui RR, Li SJ, Liu LJ, et al. MicroRNA-204 regulates vascular smooth muscle cell calcification in vitro and in vivo. Cardiovasc Res. 2012;96:320–329.
    1. Dhore CR, Cleutjens JP, Lutgens E, et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2001;21:1998–2003.
    1. Bostrom KI, Rajamannan NM, Towler DA. The regulation of valvular and vascular sclerosis by osteogenic morphogens. Circ Res. 2011;109:564–577.
    1. Lim K, Lu TS, Molostvov G, et al. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Circulation. 2012;125:2243–2255.
    1. Taïbi F, Metzinger-Le Meuth V, Massy ZA, et al. MiR-223: An inflammatory oncomiR enters the cardiovascular field. Biochim Biophys Acta. 2014;1842:1001–1009.
    1. Taïbi F, Metzinger-Le Meuth V, Massy ZA, et al. MiRNA-221 and miRNA-222 synergistically function to promote vascular calcification. Cell Biochem Funct. 2014;32:209–216.
    1. Budoff MJ, Hokanson JE, Nasir K, et al. Progression of coronary artery calcium predicts all-cause mortality. JACC: Cardiovascular Imaging. 2010;3:1229–1236.
    1. Hou Z, Lu B, Gao Y, et al. Prognostic value of coronary CT angiography and calcium score for major adverse cardiac events in outpatients. JACC Cardiovasc Imaging. 2012;5:990–999.
    1. Saremi A, Bahn G, Reaven PD. Progression of vascular calcification is increased with statin use in the veterans affairs diabetes trial (VADT) Diabetes Care. 2012;35:2390–2392.
    1. Coylewright M, Rice K, Budoff MJ, et al. Differentiation of severe coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2011;219:616–622.
    1. Coylewright M, Rice K, Budoff MJ, et al. Differentiation of severe coronary artery calcification in the multi-ethnic study of atherosclerosis. Atherosclerosis. 2011;219:616–622.
    1. Ehara S, Kobayashi Y, Yoshiyama M, et al. Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study. Circulation. 2004;110:3424–3429.
    1. van Velzen JE, de Graaf FR, Jukema JW, et al. Comparison of the relation between the calcium score and plaque characteristics in patients with acute coronary syndrome versus patients with stable coronary artery disease, assessed by computed tomography angiography and virtual histology intravascular ultrasound. Am J Cardiol. 2011;108:658–664.
    1. Criqui MH, Denenberg JO, Ix JH, et al. Calcium density of coronary artery plaque and risk of incident cardiovascular events. JAMA. 2014;311:271–278.
    1. Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827–832.
    1. de Araújo Gonçalves P, Garcia-Garcia HM, Carvalho MS, et al. Diabetes as an independent predictor of high atherosclerotic burden assessed by coronary computed tomography angiography: the coronary artery disease equivalent revisited. Int J Cardiovasc Imaging. 2013;29:1105–1114.
    1. Anand DV, Lim E, Hopkins D, et al. Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur Heart J. 2006;27:713–721.
    1. Becker A, Leber AW, Becker C, et al. Predictive value of coronary calcifications for future cardiac events in asymptomatic patients with diabetes mellitus: a prospective study in 716 patients over 8 years. BMC Cardiovasc Disord. 2008;8:27.
    1. Elkeles RS, Godsland IF, Feher MD, et al. Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study. Eur Heart J. 2008;29:2244–2251.
    1. Scholte AJ, Schuijf JD, Kharagjitsingh AV, et al. Prevalence of coronary artery disease and plaque morphology assessed by multi-slice computed tomography coronary angiography and calcium scoring in asymptomatic patients with type 2 diabetes. Heart. 2008;94:290–295.
    1. Budoff MJ, Nasir K, McClelland RL, et al. Coronary calcium predicts events better with absolute calcium scores than age-sex-race/ethnicity percentiles. J Am Coll Cardiol. 2009;53:345–352.
    1. Greenland P, LaBree L, Azen SP, et al. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA. 2004;291:210–215.
    1. Yamamoto H, Imazu M, Hattori Y, et al. Predicting angiographic narrowing > or = 50% in diameter in each of the three major arteries by amounts of calcium detected by electron beam computed tomographic scanning in patients with chest pain. Am J Cardiol. 1998;81:778–780.
    1. Budoff MJ, Malpeso JM. Is coronary artery calcium the key to assessment of cardiovascular risk in asymptomatic adults? J Cardiovasc Comput Tomogr. 2011;5:12–15.
    1. Hou ZH, Lu B, Gao Y, et al. Prognostic value of coronary CT angiography and calcium score for major adverse cardiac events in outpatients. JACC Cardiovasc Imaging. 2012;5:990–999.
    1. Hulten E, Bittencourt MS, Ghoshhajra B, et al. Incremental prognostic value of coronary artery calcium score versus CT angiography among symptomatic patients without known coronary artery disease. Atherosclerosis. 2014;233:190–195.
    1. Choi EK, Choi SI, Rivera JJ, et al. Coronary computed tomography angiography as a screening tool for the detection of occult coronary artery disease in asymptomatic individuals. J Am Coll Cardiol. 2008;52:357–365.
    1. Choi EK, Choi SI, Rivera JJ, et al. Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial. J Am Coll Cardiol. 2005;46:166–172.
    1. Motro M, Shemesh J. Calcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics. Hypertension. 2001;37:1410–1413.
    1. Manson JE, Allison MA, Rossouw JE, et al. Estrogen therapy and coronary-artery calcification. N Engl J Med. 2007;356:2591–2602.
    1. Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int. 2002;62:245–252.
    1. Qunibi W, Moustafa M, Muenz LR, et al. A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study. Am J Kidney Dis. 2008;51:952–965.
    1. Budoff MJ, Ahmadi N, Gul KM, et al. Aged garlic extract supplemented with B vitamins, folic acid and L-arginine retards the progression of subclinical atherosclerosis: a randomized clinical trial. Prev Med. 2009;49:101–107.
    1. Zeb I, Ahmadi N, Nasir K, et al. Aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. J Cardiovasc Dis Res. 2012;3:185–190.
    1. Zhang YJ, Zhu LL, Bourantas CV, et al. The impact of everolimus versus other rapamycin derivative-eluting stents on clinical outcomes in patients with coronary artery disease: A meta-analysis of 16 randomized trials. J Cardiol. 2014;64:185–193.
    1. Bourantas CV, Zhang YJ, Garg S, et al. Prognostic implications of coronary calcification in patients with obstructive coronary artery disease treated by percutaneous coronary intervention: a patient-level pooled analysis of 7 contemporary stent trials. Heart. 2014;100:1158–1164.
    1. Fitzgerald PJ, Ports TA, Yock PG. Contribution of localized calcium deposits to dissection after angioplasty. An observational study using intravascular ultrasound. Circulation. 1992;86:64–70.
    1. Díaz JF, Gómez-Menchero A, Cardenal R, et al. Extremely high-pressure dilation with a new noncompliant balloon. Tex Heart Inst J. 2012;39:635–638.
    1. Barath P, Fishbein MC, Vari S, et al. Cutting balloon: a novel approach to percutaneous angioplasty. Am J Cardiol. 1991;68:1249–1252.
    1. Mauri L, Bonan R, Weiner BH, et al. Cutting balloon angioplasty for the prevention of restenosis: results of the cutting balloon global randomized trial. Am J Cardiol. 2002;90:1079–1083.
    1. Albiero R, Silber S, Di Mario C, et al. Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT) J Am Coll Cardiol. 2004;43:943–949.
    1. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124:e574–e651.
    1. Moussa I, Ellis SG, Jones MI, et al. Impact of coronary culprit lesion calcium in patients undergoing paclitaxel-eluting stent implantation (a TAXUS-IV sub study) Am J Cardiol. 2005;96:1242–1247.
    1. Bangalore S, Vlachos HA, Selzer F, et al. Percutaneous coronary intervention of moderate to severe calcified coronary lesions: insights from the national heart, lung, and blood institute dynamic registry. Catheter Cardiovasc Interv. 2011;77:22–28.
    1. Zhang BC, Wang C, Li WH, et al. Clinical outcome of drug-eluting versus bare metal stents in patients with calcified coronary lesions: a meta-analysis. Intern Med J. 2015;45:203–211.
    1. Zimarino M, Corcos T, Bramucci E, et al. Rotational atherectomy: a “survivor” in the drug-eluting stent era. Cardiovasc Revasc Med. 2012;13:185–192.
    1. MacIsaac AI, Bass TA, Buchbinder M, et al. High speed rotational atherectomy: outcome in calcified and noncalcified coronary artery lesions. J Am Coll Cardiol. 1995;26:731–736.
    1. Kume T, Okura H, Kawamoto T, et al. Assessment of the histological characteristics of coronary arterial plaque with severe calcification. Circ J. 2007;71:643–647.
    1. Cockburn J, Hildick-Smith D, Cotton J, et al. Contemporary clinical outcomes of patients treated with or without rotational coronary atherectomy--an analysis of the UK central cardiac audit database. Int J Cardiol. 2014;170:381–387.
    1. Tomey MI, Kini AS, Sharma SK. Current status of rotational atherectomy. JACC Cardiovasc Interv. 2014;7:345–353.
    1. Lee Y, Tanaka A, Mori N, et al. Thin-strut drug-eluting stents are more favorable for severe calcified lesions after rotational atherectomy than thick-strut drug-eluting stents. J Invasive Cardiol. 2014;26:41–45.
    1. Bittl JA, Sanborn TA, Tcheng JE, et al. Clinical success, complications and restenosis rates with excimer laser coronary angioplasty. The percutaneous excimer laser coronary angioplasty registry. Am J Cardiol. 1992;70:1533–1539.
    1. Mintz GS, Kovach JA, Pichard AD, et al. Intravascular ultrasound findings after excimer laser coronary angioplasty. Cathet Cardiovasc Diagn. 1996;37:113–118.
    1. Badr S, Ben-Dor I, Dvir D, et al. The state of the excimerlaser for coronary intervention in the drug-eluting stent era. Cardiovasc Revasc Med. 2013;14:93–98.
    1. Parikh K, Chandra P, Choksi N, et al. Safety and feasibility of orbital atherectomy for the treatment of calcified coronary lesions: the ORBIT I trial. Catheter Cardiovasc Interv. 2013;81:1134–1139.
    1. Chambers JW, Feldman RL, Himmelstein SI, et al. Pivotal trial to evaluate the safety and efficacy of the orbital atherectomy system in treating de novo, severely calcified coronary lesions (ORBIT II) JACC Cardiovasc Interv. 2014;7:510–518.
    1. Castagna MT, Mintz GS, Ohlmann P, et al. Incidence, location, magnitude, and clinical correlates of saphenous vein graft calcification: an intravascular ultrasound and angiographic study. Circulation. 2005;111:1148–1152.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться